We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
CIRS

Download Mobile App





Lunit Unveils AI-Based Mammography Solution at RSNA 2018

By MedImaging International staff writers
Posted on 26 Nov 2018
Print article
Image: The Lunit INSIGHT for Mammography is expected to increase the cancer detection rate of radiologists by 10% when used as a second reader (Photo courtesy of Lunit).
Image: The Lunit INSIGHT for Mammography is expected to increase the cancer detection rate of radiologists by 10% when used as a second reader (Photo courtesy of Lunit).
Lunit (Seoul, South Korea), a medical artificial intelligence (AI) software company, showcased its newest AI solution for breast cancer—Lunit INSIGHT for Mammography— at this year's gathering of Radiological Society North America (RSNA), which was held on November 25-30 at McCormick Place in Chicago, Ill., USA.

Lunit, abbreviated from "learning unit," is focused on developing advanced medical image analytics and data-driven imaging biomarkers via cutting-edge deep learning technology. The company’s mission is to empower physicians with clinically actionable insights that foster accurate and cost-efficient diagnosis and treatment through unprecedented AI-powered imaging biomarkers with cutting-edge, world-leading accuracy.

Lunit's newest AI software, Lunit INSIGHT for Mammography delivers an accuracy of 97% in detecting malignant lesions, which is expected to increase the cancer detection rate of radiologists by 10% when used as a second reader. The company also claims that its AI solution can enable general radiologists to perform at a specialist level, providing solutions to health facilities that experience strains with lack of specialists. It also aims to decrease recall rate and as a result, save medical costs that are being wasted every year.

At RSNA 2018, the company also showcased Lunit INSIGHT for Chest Radiography, which has been tested in more than 1.5 million cases from more than 70 countries since being launched during last year's RSNA. With an accuracy level of 97-99%, it detects major chest abnormalities including nodules, consolidation, pneumothorax, etc. The CAD-based solution is also being integrated into the worklist for prioritization, in which positive cases may be read first in order to decrease turnaround time and increase overall reading productivity.

Lunit's proprietary AI technology has been trained with vast quality medical data to ensure high accuracy levels. The company’s AI has been trained with over 200,000 chest X-ray cases and 200,000 mammogram cases, out of which 50,000 cases were biopsy-proven malignant cases.

Lunit also presented six abstracts during RSNA 2018, consisting mainly of its latest findings and studies based on its AI technology in medical imaging such as mammography and chest radiography. Lunit’s new CEO Brandon Suh was on stage at Machine Learning Theater to give a presentation titled, “From AI-powered Diagnostic Support Tools to Imaging Biomarkers: Aiming Beyond Human-Level Accuracy,” which provided an overview of the company’s recent achievements and future developments.

Related Links:
Lunit

Print article
Sun Nuclear
Radcal

Channels

Radiography

view channel
Image: CE-marked and FDA-cleared ExacTrac Dynamic enables the delivery of precision radiotherapy (Photo courtesy of Brainlab)

Next-Gen Technology Enables Precision Radiotherapy with “On-The-Fly” X-Ray Confirmation

Deep Inspiration Breath Hold (DIBH) is a well-established technique and standard of care in treating breast cancer with radiation therapy. When a patient takes a deep breath, the distance between the heart... Read more

MRI

view channel
Image: fMRI can be used as non-invasive method for predicting complications in chronic liver disease (Photo courtesy of Pexels)

Functional MRI (fMRI) Offers Non-Invasive Method for Risk Assessment in Liver Disease

In a recent study, a team of scientists has shown that functional magnetic resonance imaging (fMRI) can be used as a non-invasive method for predicting complications in chronic liver disease.... Read more

Ultrasound

view channel
Image: Resona I9 ultrasound system features innovative design elements (Photo courtesy of Mindray)

Mindray’s Latest Resona I9 Ultrasound System Provides Innovation-Driven Experience

Mindray (Shenzhen, China) has launched a new ultrasound system which provides an entirely new experience, driven by innovation to address today’s clinical challenges. Mindray’s latest Resona I9 ultrasound... Read more

Imaging IT

view channel
Illustration

Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology

The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more

Industry News

view channel
Image: Global diagnostic imaging market is driven by technological advancements (Photo courtesy of Pexels)

Global Diagnostic Imaging Market to Surpass USD 33 Billion by 2026

The global diagnostic imaging market is one of the most critical segments of the healthcare sector. Medical imaging helps in early detection and diagnosis of diseases at a stage when they can be easily... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.